Purely based on the size of this company in dollar terms SR is over paid. Let’s not forget that SR presided over the decision to get in with the big boys and purchase Teva products for somewhere around a billion Aussie dollars to increase share holder value, presumably to rocket MYX onwards and upwards and burn all of those pesky shorts. Reminds me of watching a rocket on the launching pad about to lift off and watching it rise a few feet and then explode in spectacular fashion... Myx now trades at $680 000 000 some $320 000 000 below the Teva deal 4 years ago. This was all done to create share holder value but in the end it was massive, massive destruction of share holder value by a guy who was totally out of his depth. Doesn’t exactly instill confidence, hence share price downwards correction of 80% since Teva CR. So now it’s all about the next promise of great wealth from another company’s drug development so let’s see how all that goes going forwards. Anything can happen here. E4 has great prospects apparently but it’s yet to be approved and tested for sales in the marketplace and that’s what most of the hype is all about given the Myring stagnation.
MYX Price at posting:
40.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)